Persistent tumor cells in bone marrow of non-metastatic breast cancer patients after primary surgery are associated with inferior outcome.

BMC cancer

Volumn 12, Issue , 2012, Pages

  Tjensvoll, Kjersti ^a   Oltedal, Satu ^b   Heikkilä, Reino ^b   Kvaløy, Jan Terje ^b   Gilje, Bjørnar ^b   Reuben, James M ^b   Smaaland, Rune ^b   Nordgård, Oddmund ^b  

^a STAVANGER UNIVERSITY HOSPITAL   (Norway)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKERATIN 19; MAMMAGLOBIN A; NUCLEAR PROTEIN; TRANSCRIPTION FACTOR TWIST; TUMOR MARKER; TWIST1 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; BONE MARROW; BREAST TUMOR; CANCER STAGING; FEMALE; GENETICS; HUMAN; MIDDLE AGED; MORTALITY; PATHOLOGY; PROGNOSIS; TIME;

ADULT; AGED; AGED, 80 AND OVER; BONE MARROW; BREAST NEOPLASMS; FEMALE; HUMANS; KERATIN-19; MAMMAGLOBIN A; MIDDLE AGED; NEOPLASM STAGING; NUCLEAR PROTEINS; PROGNOSIS; TIME FACTORS; TUMOR MARKERS, BIOLOGICAL; TWIST TRANSCRIPTION FACTOR;

MLCS; MLOWN;

EID: 84861448522     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-12-190     Document Type: Article

References (0)